Literature DB >> 18534525

In vitro investigation of orthopedic titanium-coated and brushite-coated surfaces using human osteoblasts in the presence of gentamycin.

Akif Ince1, Norbert Schütze, Christian Hendrich, Roger Thull, Jochen Eulert, Jochen F Löhr.   

Abstract

Anti-infective coatings have been developed to protect the surfaces of cementless implants from bacterial colonization that is known to be a prerequisite for device-related infection. The aim of this study is to investigate the effect of brushite-coated arthroplasty surfaces on human osteoblasts and to evaluate the impact of concomitant exposure to gentamycin. We cultured human osteoblasts (hFOB 1.19) on brushite-coated and uncoated titanium alloy in the presence of gentamycin and analyzed cell function and vitality. Our results show that brushite-coated titanium alloy surfaces supported the function of osteoblasts and the expression of extracellular matrix even in the presence of highly dosed gentamycin. Brushite-coated titanium alloy surfaces supported osteogenic function, indicating that this coating could enhance implant osteointegration in vivo. Concomitant exposure to gentamycin slightly decreased osteoblastic activity in vitro, suggesting that there might also be negative effects in vivo. However, in vivo studies are necessary to validate these in vitro findings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534525     DOI: 10.1016/j.arth.2007.06.018

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  9 in total

1.  Decreasing bacterial colonization of external fixation pins through nitric oxide release coatings.

Authors:  Joshua Holt; Brian Hertzberg; Paul Weinhold; Wesley Storm; Mark Schoenfisch; Laurence Dahners
Journal:  J Orthop Trauma       Date:  2011-07       Impact factor: 2.512

2.  Modification of titanium alloys surface properties by plasma electrolytic oxidation (PEO) and influence on biological response.

Authors:  Mónica Echeverry-Rendón; Oscar Galvis; Robinson Aguirre; Sara Robledo; Juan Guillermo Castaño; Félix Echeverría
Journal:  J Mater Sci Mater Med       Date:  2017-09-27       Impact factor: 3.896

3.  Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. II. Antibacterial and osteoblastic response.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  J Biomed Mater Res A       Date:  2012-10-31       Impact factor: 4.396

4.  Morphology, composition, and bioactivity of strontium-doped brushite coatings deposited on titanium implants via electrochemical deposition.

Authors:  Yongqiang Liang; Haoyan Li; Jiang Xu; Xin Li; Mengchun Qi; Min Hu
Journal:  Int J Mol Sci       Date:  2014-06-04       Impact factor: 5.923

Review 5.  Biofunctionalization of metallic implants by calcium phosphate coatings.

Authors:  Yingchao Su; Irsalan Cockerill; Yufeng Zheng; Liping Tang; Yi-Xian Qin; Donghui Zhu
Journal:  Bioact Mater       Date:  2019-05-20

Review 6.  Bioactive coatings for orthopaedic implants-recent trends in development of implant coatings.

Authors:  Bill G X Zhang; Damian E Myers; Gordon G Wallace; Milan Brandt; Peter F M Choong
Journal:  Int J Mol Sci       Date:  2014-07-04       Impact factor: 5.923

7.  Pharmacokinetics of gentamicin eluted from a regenerating bone graft substitute: In vitro and clinical release studies.

Authors:  M Stravinskas; P Horstmann; J Ferguson; W Hettwer; M Nilsson; S Tarasevicius; M M Petersen; M A McNally; L Lidgren
Journal:  Bone Joint Res       Date:  2016-09       Impact factor: 5.853

Review 8.  New Ti-Alloys and Surface Modifications to Improve the Mechanical Properties and the Biological Response to Orthopedic and Dental Implants: A Review.

Authors:  Yvoni Kirmanidou; Margarita Sidira; Maria-Eleni Drosou; Vincent Bennani; Athina Bakopoulou; Alexander Tsouknidas; Nikolaos Michailidis; Konstantinos Michalakis
Journal:  Biomed Res Int       Date:  2016-01-14       Impact factor: 3.411

9.  Intraoperative loading of calcium phosphate-coated implants with gentamicin prevents experimental Staphylococcus aureus infection in vivo.

Authors:  Keith Thompson; Stoyan Petkov; Stephan Zeiter; Christoph M Sprecher; R Geoff Richards; T Fintan Moriarty; Henk Eijer
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.